BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-12-11: Reporting owner Morgan Henry; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-12-11: Reporting owner Morgan Henry; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-10-28: Reporting owner Wegman Thomas; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-09-22: Reporting owner Geller Matthew; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-12-11 | Morgan Henry Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 174,425 owned after | $2.56 exercise price | 2009-12-15 | |
| 2009-12-11 | Morgan Henry Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 164,425 owned after | $1.00 exercise price | 2009-12-15 | |
| 2009-10-28 | Wegman Thomas Director, Officer (President), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 0 owned after | $1.88 exercise price | 2009-10-30 | |
| 2009-09-22 | Geller Matthew Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 45,000 owned after | $30.79 exercise price | 2009-09-24 | |
| 2009-09-15 | Gitman Paul Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 164,425 owned after | $1.00 exercise price | 2010-05-05 | |
| 2009-09-15 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 164,425 owned after | $1.00 exercise price | 2009-09-15 | |
| 2009-09-14 | Gitman Paul Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 174,425 owned after | $2.56 exercise price | 2010-05-05 | |
| 2009-09-14 | Gitman Paul Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 169,425 owned after | $1.00 exercise price | 2010-05-05 | |
| 2009-09-14 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 174,425 owned after | $2.56 exercise price | 2009-09-15 | |
| 2009-09-14 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 169,425 owned after | $1.00 exercise price | 2009-09-15 | |
| 2009-09-11 | Gitman Paul Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 180,425 owned after | $2.56 exercise price | 2010-05-05 | |
| 2009-09-11 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 180,425 owned after | $2.56 exercise price | 2009-09-15 | |
| 2009-09-08 | Schamroth Michael Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 109,000 owned after | $26.43 exercise price | 2010-01-20 | |
| 2009-09-08 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 184,425 owned after | $26.43 exercise price | 2009-09-11 | |
| 2009-09-08 | Morgan Henry Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 184,425 owned after | $26.43 exercise price | 2009-09-11 | |
| 2009-09-08 | Schamroth Michael Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 109,000 owned after | $26.43 exercise price | 2009-09-11 | |
| 2009-07-12 | Wegman Thomas Director, Officer (President), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −20,000 340,000 owned after | $3.00 exercise price | 2009-07-22 | |
| 2009-06-29 | Wegman Mark N Director | 4 | Stock Option (Right to Buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −15,000 30,000 owned after | $4.60 exercise price | 2009-07-01 | |
| 2009-06-25 | Wegman Mark N Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 45,000 owned after | $20.95 exercise price | 2009-06-29 |